Literature DB >> 19577331

The burden of vitiligo: patient characteristics associated with quality of life.

May W Linthorst Homan1, Phyllis I Spuls, John de Korte, Jan D Bos, Mirjam A Sprangers, J P Wietze van der Veen.   

Abstract

BACKGROUND: Vitiligo is commonly regarded as a harmless cosmetic skin problem in Western societies, and the importance of treating patients with vitiligo is often underestimated.
OBJECTIVE: We sought to determine the clinical and sociodemographic variables that adversely affect the quality of life in adult patients with generalized vitiligo so that these variables can be considered in the treatment and care.
METHODS: A total of 245 adult patients with generalized vitiligo completed two quality-of-life questionnaires (the Medical Outcomes Study 36-Item Short-form General Health Survey and the Skindex-29). Physicians assessed sociodemographic and clinical characteristics of these patients.
RESULTS: Dark skin type, vitiligo located on the chest, and treatment in the past appeared to have an adverse impact on the psychosocial domains of quality of life. Moreover, itch was reported by 20% of the patients in this study. LIMITATIONS: Psychiatric comorbidity was not evaluated in the analyses.
CONCLUSION: Generalized vitiligo is a serious skin disorder with an adverse impact on the emotional state, comparable with that of other major skin diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19577331     DOI: 10.1016/j.jaad.2009.03.022

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  29 in total

1.  Quality of life in dermatomyositis.

Authors:  Renato Goreshi; Monika Chock; Kristen Foering; Rui Feng; Joyce Okawa; Matt Rose; David Fiorentino; Victoria Werth
Journal:  J Am Acad Dermatol       Date:  2011-07-01       Impact factor: 11.527

2.  The impact of skin damage due to cutaneous lupus on quality of life.

Authors:  S M Verma; J Okawa; K J Propert; V P Werth
Journal:  Br J Dermatol       Date:  2014-02       Impact factor: 9.302

Review 3.  The Role of Memory CD8+ T Cells in Vitiligo.

Authors:  Rebecca L Riding; John E Harris
Journal:  J Immunol       Date:  2019-07-01       Impact factor: 5.422

4.  Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.

Authors:  Lucy Y Liu; James P Strassner; Maggi A Refat; John E Harris; Brett A King
Journal:  J Am Acad Dermatol       Date:  2017-08-18       Impact factor: 11.527

5.  Successful treatment of extensive vitiligo with monobenzone.

Authors:  Ole Martin Rordam; Eric William Lenouvel; Martine Maalo
Journal:  J Clin Aesthet Dermatol       Date:  2012-12

6.  Rapid response of facial vitiligo to 308nm excimer laser and topical calcipotriene.

Authors:  John A Mouzakis; Stephanie Liu; George Cohen
Journal:  J Clin Aesthet Dermatol       Date:  2011-06

7.  Reduced serum paraoxonase-1 levels in vitiligo: further evidence of oxidative stress.

Authors:  Yavuz Yesilova; Enver Turan; Derya Ucmak; Sahabettin Selek; İbrahim Halil Yavuz; Osman Tanrıkulu
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

Review 8.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

9.  Vitiligo and alopecia areata: apples and oranges?

Authors:  John E Harris
Journal:  Exp Dermatol       Date:  2013-12       Impact factor: 3.960

Review 10.  Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.

Authors:  Yinghan Wang; Shuli Li; Chunying Li
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-20       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.